With $19.5 million in new financing fuel, Boulder, Colo.-based SomaLogic is readying to launch its price-busting aptamer protein microarrays by the fourth quarter this year, according to David Brunel, the company’s CEO.
The financing, a series C round closed Feb. 20, will be used mostly for R&D on the aptamer arrays, the company said.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
